Previous 10 | Next 10 |
2024-05-02 16:56:00 ET Investors were meowing for animal healthcare specialist Zoetis (NYSE: ZTS) on Thursday, following the company's release of its latest quarterly results. These obviously pleased market participants, as the stock's price leaped nearly 6% higher over the course o...
2024-05-02 13:25:26 ET Zoetis Inc (ZTS) Q1 2024 Results Conference Call May 02, 2024 08:30 AM ET Company Participants Steve Frank - Vice President of Investor Relations Kristin Peck - Chief Executive Officer Wetteny Joseph - Chief Financial Officer Conferen...
2024-05-02 11:40:03 ET More on Zoetis Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment Zoetis: My Favorite Healthcare Stock Right Now Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness Zoetis Non-GAAP EPS of $1.38 beats by $0.04,...
2024-05-02 07:04:10 ET More on Zoetis Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment Zoetis: My Favorite Healthcare Stock Right Now Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness Zoetis Q1 2024 Earnings Preview Zoet...
2024-05-02 07:00:00 ET Summary Value investors have been frustrated as growth stocks have outperformed for the past 15 years. Value investing is a long-term strategy that requires patience and a focus on fundamentals. Three blue-chip stocks, Bristol-Myers, Zoetis, and Monster ...
Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 Delivers 12% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for First ...
2024-05-01 16:36:45 ET Summary Phibro Animal Health has seen lackluster performance over the past decade, seeing modest sales growth and declining margins. The company recently announced a significant deal with Zoetis, acquiring their medicated feed additive product portfolio for ...
2024-05-01 11:30:57 ET More on Zoetis Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment Zoetis: My Favorite Healthcare Stock Right Now Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness Zoetis to sell medicated feed additive portf...
2024-04-30 07:00:00 ET So far, 2024 has been a year to forget for animal healthcare juggernaut Zoetis (NYSE: ZTS) . Hit by the triple whammy of weak earnings, a formal investigation from the European Commission, and adverse events linked to some of its newest medicines, Zoetis has s...
2024-04-29 13:17:15 ET More on S&P 500 Index: Soft Landing On Track, With New All-Time Highs Ahead Yen Dumps Before It Jumps S&P 500: Trade Of The Year. Week Starting 29th April (Technical Analysis) Nasdaq, S&P, and Dow rise with the latest Fed de...
News, Short Squeeze, Breakout and More Instantly...
2024-07-05 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, August 6, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2024 financial results and respond to questions fr...
Zoetis Foundation provides $3 million grant to the American Red Cross to be utilized over a six-year period to support disaster relief globally Zoetis Inc. launches consumer matching campaign with long-time partner American Humane to support pets impacted by natural disasters across the c...